Shinpoong Pharmaceutical Co., Ltd.(KR:019170)
₩7,920.00-110.00 (-1.37%)
KR:019170
Shinpoong Pharmaceutical Co., Ltd. financials statements
₩7,920.00
At close:-110.00 (-1.37%)
Want to see KR:019170 full AI Analyst Report?
Shinpoong Pharmaceutical Co., Ltd. (019170) Ratios
Shinpoong Pharmaceutical Co., Ltd. Ratios
KR:019170's free cash flow for Q2 2026 was ₩-2.50B. For the 2026 fiscal year, KR:019170's free cash flow was decreased by ₩-1.36B and operating cash flow was ₩-1.15B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.09 | 2.50 | 2.60 | 7.23 | 7.96 |
| Quick Ratio | 2.22 | 1.77 | 1.90 | 5.51 | 6.29 |
| Cash Ratio | 0.71 | 0.55 | 0.57 | 1.53 | 0.97 |
| Solvency Ratio | 0.25 | -0.04 | -0.57 | -0.73 | 0.03 |
| Operating Cash Flow Ratio | 0.26 | -0.20 | -0.33 | -0.97 | -2.49 |
| Short-Term Operating Cash Flow Coverage | 0.40 | -0.31 | -0.55 | 0.00 | -286.27 |
| Net Current Asset Value | ₩ 125.00B | ₩ 105.32B | ₩ 119.63B | ₩ 165.76B | ₩ 189.21B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.16 | 0.16 | 0.13 | 0.01 | 0.00 |
| Debt-to-Equity Ratio | 0.21 | 0.21 | 0.17 | 0.01 | 0.00 |
| Debt-to-Capital Ratio | 0.17 | 0.18 | 0.15 | 0.01 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.04 | 0.02 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.31 | 1.33 | 1.30 | 1.10 | 1.11 |
| Debt Service Coverage Ratio | 0.55 | -0.02 | -0.93 | -365.41 | -2.81 |
| Interest Coverage Ratio | 5.30 | -7.77 | -27.58 | -553.86 | -44.76 |
| Debt to Market Cap | 0.07 | 0.10 | 0.06 | 0.00 | 0.00 |
| Interest Debt Per Share | 1060.88 | 1075.28 | 934.43 | 38.81 | 26.97 |
| Net Debt to EBITDA | 0.33 | -464.63 | -0.06 | 1.81 | -20.75 |
| Profitability Margins | |||||
| Gross Profit Margin | 43.62% | 37.00% | 40.09% | 37.26% | 40.89% |
| EBIT Margin | 6.07% | -5.42% | -25.83% | -16.59% | -4.64% |
| EBITDA Margin | 10.93% | -0.01% | -19.88% | -10.47% | 0.67% |
| Operating Profit Margin | 6.07% | -9.25% | -23.67% | -16.25% | -4.78% |
| Pretax Profit Margin | 3.60% | -6.61% | -26.69% | -16.62% | -4.75% |
| Net Profit Margin | 3.76% | -6.96% | -28.63% | -16.87% | -6.09% |
| Continuous Operations Profit Margin | 3.57% | -6.95% | -28.60% | -16.87% | -6.09% |
| Net Income Per EBT | 104.42% | 105.23% | 107.27% | 101.52% | 128.27% |
| EBT Per EBIT | 59.29% | 71.48% | 112.76% | 102.24% | 99.34% |
| Return on Assets (ROA) | 2.50% | -4.50% | -16.37% | -9.77% | -2.94% |
| Return on Equity (ROE) | 3.27% | -5.99% | -21.26% | -10.71% | -3.26% |
| Return on Capital Employed (ROCE) | 4.99% | -7.68% | -17.32% | -10.17% | -2.48% |
| Return on Invested Capital (ROIC) | 4.29% | -6.48% | -14.83% | -10.13% | -2.48% |
| Return on Tangible Assets | 2.54% | -4.56% | -16.65% | -9.96% | -3.00% |
| Earnings Yield | 1.14% | -2.80% | -8.13% | -3.36% | -0.70% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.19 | 3.05 | 2.44 | 2.31 | 2.09 |
| Payables Turnover | 18.64 | 13.93 | 13.42 | 11.49 | 9.27 |
| Inventory Turnover | 2.26 | 2.52 | 2.22 | 2.80 | 2.34 |
| Fixed Asset Turnover | 2.16 | 1.92 | 1.69 | 1.84 | 1.62 |
| Asset Turnover | 0.67 | 0.65 | 0.57 | 0.58 | 0.48 |
| Working Capital Turnover Ratio | 1.85 | 1.87 | 1.37 | 1.14 | 0.84 |
| Cash Conversion Cycle | 256.10 | 238.65 | 286.54 | 256.80 | 290.62 |
| Days of Sales Outstanding | 114.36 | 119.73 | 149.67 | 158.21 | 174.30 |
| Days of Inventory Outstanding | 161.32 | 145.12 | 164.08 | 130.35 | 155.68 |
| Days of Payables Outstanding | 19.58 | 26.20 | 27.21 | 31.77 | 39.36 |
| Operating Cycle | 275.67 | 264.85 | 313.75 | 288.56 | 329.98 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 312.65 | -284.75 | -485.03 | -515.85 | -1385.58 |
| Free Cash Flow Per Share | 249.64 | -399.15 | -778.43 | -637.36 | -1495.11 |
| Dividend Paid and CapEx Coverage Ratio | 4.96 | -2.49 | -1.65 | -4.25 | -6.59 |
| Capital Expenditure Coverage Ratio | 4.96 | -2.49 | -1.65 | -4.25 | -12.65 |
| Operating Cash Flow Coverage Ratio | 0.31 | -0.28 | -0.54 | -13.71 | -60.16 |
| Operating Cash Flow to Sales Ratio | 0.07 | -0.07 | -0.12 | -0.13 | -0.38 |
| Free Cash Flow Yield | 1.78% | -3.87% | -5.65% | -3.11% | -4.68% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 81.63 | -34.35 | -12.31 | -29.76 | -142.10 |
| Price-to-Sales (P/S) Ratio | 3.30 | 2.48 | 3.52 | 5.02 | 8.65 |
| Price-to-Book (P/B) Ratio | 2.87 | 2.14 | 2.62 | 3.19 | 4.63 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 56.24 | -25.83 | -17.69 | -32.16 | -21.37 |
| Price-to-Operating Cash Flow Ratio | 44.91 | -36.21 | -28.39 | -39.74 | -23.06 |
| Price-to-Earnings Growth (PEG) Ratio | -0.52 | 0.47 | -0.20 | -0.14 | 0.44 |
| Enterprise Value Multiple | 30.54 | -20681.22 | -17.78 | -46.13 | 1264.07 |
| Enterprise Value | 783.22B | 561.33B | 707.78B | 1.01T | 1.61T |
| EV to EBITDA | 30.54 | -20681.22 | -17.78 | -46.13 | 1264.07 |
| EV to Sales | 3.34 | 2.54 | 3.53 | 4.83 | 8.52 |
| EV to Free Cash Flow | 56.85 | -26.42 | -17.75 | -30.95 | -21.02 |
| EV to Operating Cash Flow | 45.39 | -37.04 | -28.48 | -38.24 | -22.69 |
| Tangible Book Value Per Share | 4813.66 | 4755.24 | 5173.09 | 6317.07 | 6741.58 |
| Shareholders’ Equity Per Share | 4892.18 | 4825.46 | 5262.36 | 6429.82 | 6895.75 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | -0.05 | -0.07 | -0.02 | -0.28 |
| Revenue Per Share | 4252.62 | 4154.19 | 3908.49 | 4082.68 | 3691.55 |
| Net Income Per Share | 159.92 | -289.11 | -1119.00 | -688.79 | -224.84 |
| Tax Burden | 1.04 | 1.05 | 1.07 | 1.02 | 1.28 |
| Interest Burden | 0.59 | 1.22 | 1.03 | 1.00 | 1.02 |
| Research & Development to Revenue | 0.05 | 0.08 | 0.28 | 0.15 | 0.09 |
| SG&A to Revenue | 0.12 | 0.15 | 0.18 | 0.17 | 0.16 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.96 | 0.99 | 0.43 | 0.75 | 6.16 |
Currency in KRW

